Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants


Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to patient-derived gastrointestinal tumors (GIST) and paraganglioma tumors that harbor genetic mutations that have an effect on early stage embryogenesis.

Projects based on this Technology

Start New Project